Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-24-035474

President and CEO acquired 18,028 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tesi Raymond Joseph · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-19 Grant or award : show line 1 in the form +18,028 $8.32 $149,993 1,538,726 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-19 Grant or award : show line 2 in the form Common Stock Warrants (right to buy) +18,028 $0.13 $2,254 18,028 D
Loading xslF345X05/ownership.xml…